News
We send the latest information from SMC Laboratories.
A study using liver samples from the STAM™ model published in PLOS ONE.
SMC is proud to announce that Institut de Recherches Servier (FRA) has published the results of their study us…
SMC announces Presentation of New Data at the International Congress of Endocrinology 2022 (ICE2022).
Today, we are pleased to announce the acceptance of our abstract on our NASH-hepatocellular carcinoma (HCC) mo…
Drug Efficacy Study in the STAM™ Model Published in Translational Oncology
SMC is proud to announce that Kurume University (JPN) has published the results of their study using our STAM&…
GN Corporation publication in Journal of Clinical and Experimental Hepatology
SMC announces that GN Corporation Clinical and Experimental Hepatology (Japan) has published the results of a …
Esperion Therapeutics's publication in Cell Metabolism
SMC announces that Esperion Therapeutics (MI, USA) has published the results of a study using STAM™ …
Drug efficacy studies in NASH mouse model
We would like to introduce a study published by our client using our proprietary non-alcoholic steatohepatitis…
Drug efficacy study in NASH mouse model
We would like to introduce a paper published by our client using our non-alcoholic steatohepatitis (NASH) mode…
Published papers with IPF model
We would like to share with you some examples of studies that our clients have often asked us about using the …
National Defense Medical College's publication in Surgery Open Science
SMC announces that National Defense Medical College (Japan) has published the results of a study using STAM&tr…
Our clients’ presentations at DDW 2021
Our clients presented data on treatment of NASH using STAMTM model at the DDW2021 (May 21-23). For deta…